Lazertinib in Pretreated Epidermal Growth Factor Receptor T790M-Mutated Advanced Non-small Cell Lung Cancer: A Real-World Multicenter Study

被引:0
|
作者
Ahn, B-C. [1 ,2 ]
Kim, H. [2 ]
Lee, J. [2 ]
Lee, J. B. [2 ]
Hong, M. -H. [2 ]
Kim, H. R. [2 ]
Cho, B. C. [2 ]
Lim, S. M. [2 ]
机构
[1] Natl Canc Ctr, Goyang Si, South Korea
[2] Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
关键词
Lazertinib; real-world data; T790M EGFR mutation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP12.01-47
引用
收藏
页码:S659 / S660
页数:2
相关论文
共 50 条
  • [21] Osimertinib in epidermal growth factor receptor (EGFR) T790M advanced non-small cell lung cancer (NSCLC): Analysis of patients with central nervous system (CNS) metastases in a real-world study (ASTRIS)
    Metro, G.
    Provencio, M.
    Kim, D-W.
    Cho, B. C.
    Park, K.
    Pan, Y.
    Shi, Y.
    Migliorino, R.
    Tiseo, M.
    Yu, J.
    Zhou, Q.
    Santo, A.
    Ardizzoni, A.
    Hu, Y.
    Wu, Y-L.
    Kim, S-W.
    Miranda, M.
    Fernandes, A.
    de Marinis, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 624 - 624
  • [22] Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients
    Araujo Barros Coelho, David Jorge
    Sousa, Catarina
    Jacob, Maria
    Almeida, Leonor
    Araujo, David
    Novais-Bastos, Helder
    Magalhaes, Adriana
    Moura, Conceicao Souto
    Cirnes, Luis
    Hespanhol, Venceslau
    Queiroga, Henrique
    Fernandes, Gabriela
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [23] Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Peng, Da
    Shan, Dongfeng
    Dai, Chengcheng
    Li, Jie
    Wang, Zifan
    Huang, Ziyi
    Peng, Rui
    Zhao, Peng
    Ma, Xuezhen
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2033 - 2039
  • [24] Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer
    Gregorc, Vanesa
    Lazzari, Chiara
    Karachaliou, Niki
    Rosell, Rafael
    Santarpia, Mariacarmela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S165 - S170
  • [25] Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment Paradigm
    Pakkala, Suchita
    Ramalingam, Suresh S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 83 - +
  • [26] Real-world study of lazertinib as second-line or greater treatment in advanced non-small cell lung cancer
    Lim, Jeong Uk
    Kim, Kyuhwan
    Kim, Kyu Yean
    Kang, Hye Seon
    Shin, Ah. Young
    Yeo, Chang Dong
    Kim, Sung Kyoung
    Park, Chan Kwon
    Lee, Sang Haak
    Kim, Seung Joon
    THORACIC CANCER, 2024, 15 (19) : 1513 - 1521
  • [27] Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries
    Samol, J.
    Demedts, I.
    Erman, M.
    Kozlov, V.
    Minatta, J. N.
    Moiseenko, F. V.
    Paats, M. S.
    Rajappa, S. J.
    Bailey, T.
    Wallis, H.
    Madondo, M.
    Kahangire, D.
    Zukin, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S55 - S56
  • [28] Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples
    Kiura, Katsuyuki
    Yoh, Kiyotaka
    Katakami, Nobuyuki
    Nogami, Naoyuki
    Kasahara, Kazuo
    Takahashi, Toshiaki
    Okamoto, Isamu
    Cantarini, Mireille
    Hodge, Rachel
    Uchida, Hirohiko
    CANCER SCIENCE, 2018, 109 (04) : 1177 - 1184
  • [29] Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer
    Velazquez, Ana, I
    McCoach, Caroline E.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2896 - 2909
  • [30] Osimertinib for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer patients with leptomeningeal metastases and different T790M status
    Xu, Haiyan
    Chen, Hengqi
    Kong, Jianxin
    Zhang, Ye
    Liu, Shan
    Yang, Guangjian
    Yang, Lu
    Wang, Yan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (11)